What is SYBX's earnings growth forecast for 2026-2026?
(NASDAQ: SYBX) Synlogic's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 205.75%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,956.79%.
Synlogic's earnings in 2025 is -$3,227,000.
In 2026, SYBX is forecast to generate -$2,744,566 in earnings, with the lowest earnings forecast at -$2,636,936 and the highest earnings forecast at -$2,825,289.
What is SYBX's revenue growth forecast for 2026-2026?
(NASDAQ: SYBX) Synlogic's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 9,145.53%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,442.9%.
Synlogic's revenue in 2025 is $0.
In 2026, SYBX is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.
What is SYBX's forecast return on assets (ROA) for 2025-2026?
(NASDAQ: SYBX) forecast ROA is -16.58%, which is lower than the forecast US Biotechnology industry average of 13.3%.
What is SYBX's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: SYBX) Synlogic's current Earnings Per Share (EPS) is -$0.26. In 2026, SYBX's EPS is forecast to hit -$0.23 (min: -$0.23, max: -$0.24).
What is SYBX's forecast return on equity (ROE) for 2025-2026?
(NASDAQ: SYBX) forecast ROE is -26.58%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.